A new androgen biosynthesis inhibitor drug improved progression-free survival in prostate cancer but did not improve overall survival compared to current therapies.
A new, smart pacemaker is integrated into a coordinated network of four soft, flexible, wireless, wearable sensors and control units placed around the upper body.
The Cancer Immunology and Immunotherapy Initiative at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University is bringing together Feinberg investigators who study immunotherapy to increase collaboration and accelerate high-impact immunotherapy research.
Most non-hospitalized COVID-19 “long-haulers” at the Northwestern Medicine Neuro COVID-19 Clinic continued to experience symptoms including brain fog, dizziness and fatigue 15 months after disease onset, according to a new study.
A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung cancer.
A new study has identified a drug that inhibits growth of aggressive meningiomas and how to most accurately identify which tumors will respond to the drug.
A transitional care practice at Northwestern Memorial Hospital helped reduce healthcare costs compared to traditional discharge services, according to a Northwestern Medicine study.
Children born to women who took antipsychotic medications later in their pregnancy did not show increased risk of neurodevelopmental disorders, according to a recent study.
A salt substitute that contains less sodium was a cost-effective intervention for prevention of stroke and improved quality of life, according to a recent study.
Higher doses of anti-seizure medications may be necessary during pregnancy, according to a recent study.
Notifications